Adverse response to endodontic material containing paraformaldehyde.
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D002610:Cheek; D003907:Dexamethasone / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D005557:Formaldehyde / Q000009:adverse effects*; D006801:Humans; D006854:Hydrocortisone; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000139:chemically induced / Q000473:pathology; D009336:Necrosis; D009422:Nervous System Diseases / Q000139:chemically induced / Q000473:pathology; D011108:Polymers / Q000009:adverse effects*; D012118:Resorcinols; D012387:Root Canal Filling Materials / Q000009:adverse effects*; D012677:Sensation / Q000187:drug effects*; D013943:Thymol / Q000009:adverse effects / Q000031:analogs & derivatives*; D014456:Ulcer / Q000139:chemically induced / Q000473:pathology
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D011108:Polymers; D012118:Resorcinols; D012387:Root Canal Filling Materials; C011244:corticosteroid methanetriol mixture; D005557:Formaldehyde; D013943:Thymol; C032784:SPAD; D003907:Dexamethasone; D006854:Hydrocortisone